Home/ Supplements/ Vitamin K/ Vitamin K2

Vitamin K2

product on market Tablet or Pill Higher Nature Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · grounded in 1 source · methodology

Vitamin K2 is researched for its role in supporting bone density and cardiovascular health by regulating calcium deposition. There is moderate evidence that it works synergistically with Vitamin D to improve calcium absorption. Current data indicates a high safety profile for general supplementation.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Vitamin K2
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Tablet(s)
Serving Size
Vitamin
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

45 mcg (60% DV)
Within RDA (0.4× RDA) 275 studies (A:9, B:175)

Other Ingredients

natural Lithothamnion calcarea Cellulose Menaquinone-7 Zein Protein Magnesium Stearate Silicon Dioxide
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Directions for Use

DIRECTIONS: Adults and children over 4 years take 1 tablet a day, or as your health professional advises. Do not exceed recommended daily intake.

Warnings & Precautions

STORAGE: Store in a cool, dry, steam free environment out of reach of children.

WARNING: Not advisable if taking warfarin or other blood thinning medication.

Formulation Notes

DOES NOT CONTAIN: Artificial colours, flavourings or preservatives, dairy products, gluten, lactose, sugar, wheat, yeast.

Suitable for vegetarians and vegans.

Additional Information

This product is not tested on animals.

FOR HEALTHY BONES & CIRCULATION

ULTIMATE NUTRITION

MenaQ7(R) Natural Vitamin K2

- Vitamin K contributes to the maintenance of normal bones. - Vitamin K contributes to normal blood clotting.

QVK060 111 QVK-348-02

Food supplements should not be used as a substitute for a varied diet.

STORAGE: Store in a cool, dry, steam free environment out of reach of children.

Jar {Recycle} 1 PET Lid {Recycle} 5 PP

Metadata

Product Details

UPC / SKU5 031013 105722
DSLD Entry Date2015-01-23
Product TypeVitamin
FormTablet or Pill
DSLD ID41350
Data Updated2026-04-11
Research

Research Evidence

332
Research Sources
59
Avg Quality
220
Meta Analysis
56
Systematic Review
30
Rct
16
Clinical Trial
3
Guideline
3
Regulatory Source
1
Narrative Review
1
Other
1
Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022 PubMed DOI
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
View all evidence for Vitamin K →
Compare

Similar Products

View all Vitamin K products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.